Automating output management when the world needed it most
The need for innovative solutions became urgent when the COVID-19 pandemic swept the globe. In such a challenging environment, Pfizer was one of the firms leading the change. In their effort to develop effective vaccines, while working on their outputs and validating them before submission, Pfizer encountered a significant bottleneck.
To address this crucial challenge, Pfizer leveraged Verify, an output management platform by Beaconcure Technologies. The company’s biostatisticians used Verify’s automation capabilities to swiftly and efficiently validate the outputs of the COVID-19 vaccine’s clinical trials. Thanks to Verify, Pfizer significantly reduced a multitude of laborious tasks and accelerated critical time-to-market.
The Results
De-risking of the Submission
Identifying discrepancies earlier in the process reduced risk and enhanced submission quality.
Being the First to Market
Expediting the release of the vaccine permeated COVID-19 protection more quickly throughout the globe.
Releasing Earlier
Releasing earlier meant more sales within the IP protection timelines.
Sign up for Verify Demo
- Intuitive and Simple
- Get Sample Data
- Personal Customer Support
